We are looking for a reliable supplier of Kief CBG, with an initial supply of 100-200 kg per month, with the possibility to increase quantities. Preferably we are looking for suppliers in Europe, but we are also open to collaborations with partners from America or other regions.
Requirements:
High standards of quality and purity
Stable and reliable supply
Compliance with local and international regulations
If interested, please contact us to discuss details and consider opportunities for long-term collaboration.
I’m not sure if @ky_cbd can help you, but that’s who I would ask first for a referral if he can’t supply it.
As far as your requirements, COAs on each batch would ensure quality. We sell nutraceuticals in the EU, so that’s going to be an issue. I don’t have a recommendation for international regulations and shipping, which is going to be your biggest hurdle if it is labeled for human consumption.
If I understand you correctly, 100-200 kg per month is really a request for 100+ kg of CBGA per month, or 1200kg per annum CBGA.
I am not sure, but wouldn’t you have to specially contract with a grower to supply like 14400kg of CBGA specific hemp-flower to produce that amount of kief?
Excepting perhaps Morocco or Afghanistan , does any where else on earth produce such amounts of kief
Your request is for CBG kief, is there any way to convert the CBGA to CBG in situ and keep the unique structure of the trichomes in Kief form?
Why not just put out a request for 100 kg CBGA a month. ? Curious?
The only person who might be able to “field” that request is @Roguelab ……
Cbg is probably as much cultivated as cbd in europe
Lithuania /Croatia/ Slovenia and Tjech all produce vas amounts
There is still biomass around 3 years old
Now quality kief is a bit harder to source the Swiss have most
As does Lithuania
Basicly the few that understand the process like @MasterG
That’s not the only reason
Adding noids to cbg lief ensures no other receptors are activated
Using cbd lief needs higher loading to compensate for this effect
Can you explain a bit more?
CBD acts as a NAM at CB1 allosteric site, so one might understand knocking the response to a full agonists, synthetic-noid down a bit.
Unless there is some study I am unaware of (highly probable) there does not seem to be similar data for CBGA action at CB1 allosteric site or orthostatic….so I don’t get this demand for CBG? Is it some sort of “weedo” folk legend/myth?